KalVista Pharmaceuticals, Inc. · 22 hours ago
Director/Senior Director, Trade & Distribution
KalVista Pharmaceuticals is a global pharmaceutical company focused on developing therapies for rare diseases. They are seeking a Director/Senior Director for Trade & Distribution to lead the market access strategy for their product EKTERLY®, managing operations related to specialty pharmacies and logistics to ensure patient access.
BiotechnologyDiabetesHealth Care
Responsibilities
Lead the US EKTERLY® trade and distribution strategy serving as primary contact for specialty pharmacies, third party logistics providers, and authorized trade partners
Negotiate and manage distribution service agreements, performance and data programs with existing network partners
Oversee limited distribution network operations to ensure optimal product availability and service levels
In partnership with KalVista Cares patient services, champion patient’s needs to ensure KalVista’s programs are ideal for supporting individuals and HCPs with regards to obtaining and maintaining therapy
Drive collaboration across the Commercial, Legal, Compliance, Quality, Supply Chain, Medical Affairs and Finance to ensure alignment on and optimal, compliant execution of channel model and patient experience
Establish, maintain and monitor distribution of physical product aligning to both internal and external partner inputs for quantity requests and ship volumes
Qualification
Required
10+ years in the biopharmaceutical industry; emphasis in US Market Access
Bachelor's degree required
Rare disease product launch experience in the US required
Experience delivering product access in competitive markets
Strong strategic thinking and problem-solving skills
Exceptional leadership and interpersonal skills with the ability to effectively engage and influence across teams
Innovative mindset with the ability to take a creative approach to best meet the needs of both customers and KalVista
Strong presentation skills, ability to present to diverse stakeholders including external partners, healthcare professionals and senior leaders
Previous experience operationalizing trade and distribution programs within small or startup pharmaceutical and biotech organizations
Preferred
MBA or relevant post graduate qualifications
Company
KalVista Pharmaceuticals, Inc.
For nearly a decade, KalVista Pharmaceuticals has been focused on addressing the critical unmet needs of those living with hereditary angioedema (HAE).
Funding
Current Stage
Public CompanyTotal Funding
$821.8MKey Investors
DRI Healthcare TrustRA Capital Management
2025-09-24Post Ipo Debt· $125M
2024-11-04Post Ipo Equity· $60M
2024-11-04Post Ipo Debt· $179M
Recent News
2026-01-11
Company data provided by crunchbase